Logo Logo
Switch Language to German
Feiterna-Sperling, C.; Brinkmann, F.; Adamczick, C.; Ahrens, F.; Barker, M.; Berger, C.; Berthold, L. D.; Bogyi, M.; Both, U. von; Frischer, T.; Haas, W.; Hartmann, P.; Hillemann, D.; Hirsch, F. W.; Kranzer, K.; Kunitz, F.; Maritz, E.; Pizzulli, A.; Ritz, N.; Schlags, R.; Spindler, T.; Thee, S.; Weizsäcker, K. (2017): S2k-Leitlinie zur Diagnostik, Prävention und Therapie der Tuberkulose im Kindes- und Jugendalter. Eine Leitlinie unter Federführung der Deutschen Gesellschaft für Pädiatrische Infektiologie (DGPI) e. V. In: Pneumologie, Vol. 71, No. 10: pp. 629-680
Full text not available from 'Open Access LMU'.


Recently, epidemiological data shows an increase of childhood tuberculosis in Germany. In addition to this, drug resistant tuberculosis becomes more frequent. Therefore, diagnosis, prevention and therapy in childhood and adolescence remain a challenge. Adult guidelines do not work for children, as there are age specific differences in manifestation, risk of progression and diagnostic as well as therapeutic pathways. The German Society for Pediatric Infectious Diseases (DGPI) has initiated a consensus-based (S2k) process and completed a paediatric guideline in order to improve and standardize care for children and adolescents with tuberculosis exposure, infection or disease. Updated dosage recommendations take age dependant pharmacokinetics in the treatment of drug sensitive but also drug resistant tuberculosis in account. In addition to this, there is a detailed chapter on perinatal exposure and disease as well as extrapulmonary manifestations.